Nguyen Van Long, F.; Lardy-Cleaud, A.; Bray, S.; Chabaud, S.; Dubois, T.; Diot, A.; Jordan, L.B.; Thompson, A.M.; Bourdon, J.-C.; Perol, D.;
et al. Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes. Cancers 2018, 10, 390.
https://doi.org/10.3390/cancers10100390
AMA Style
Nguyen Van Long F, Lardy-Cleaud A, Bray S, Chabaud S, Dubois T, Diot A, Jordan LB, Thompson AM, Bourdon J-C, Perol D,
et al. Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes. Cancers. 2018; 10(10):390.
https://doi.org/10.3390/cancers10100390
Chicago/Turabian Style
Nguyen Van Long, Flora, Audrey Lardy-Cleaud, Susan Bray, Sylvie Chabaud, Thierry Dubois, Alexandra Diot, Lee B. Jordan, Alastair M. Thompson, Jean-Christophe Bourdon, David Perol,
and et al. 2018. "Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes" Cancers 10, no. 10: 390.
https://doi.org/10.3390/cancers10100390
APA Style
Nguyen Van Long, F., Lardy-Cleaud, A., Bray, S., Chabaud, S., Dubois, T., Diot, A., Jordan, L. B., Thompson, A. M., Bourdon, J.-C., Perol, D., Bouvet, P., Diaz, J.-J., & Marcel, V.
(2018). Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes. Cancers, 10(10), 390.
https://doi.org/10.3390/cancers10100390